COMMITMENTS AND CONTINGENCIES (Details Textual) (USD $)	1 Months Ended	12 Months Ended		3 Months Ended	0 Months Ended
	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Sep. 02, 2014
COMMITMENTS AND CONTINGENCIES [Line Items]
Cost of Services		$ 340,658	$ 105,764
Research and Development Expense, Total		2,577,465	1,105,110
Capital Leased Assets, Gross		206,702
Amortization Of Capital Lease Equipment Straight Line Basis		5 years
Other Commitments, Description	On September 1, 2014, the NRLBH entered into a three year agreement with TME Research LLC (TME) which requires TME to provide to the NRLBH 100 tissue specimens in connection with the development of the NextCYTE test. Fees payable to TME under the agreement includes $99,600 up front, $31,500 upon supplying the first 25 specimens and $31,500 at the time of final delivery of all specimens. The agreement is terminable with 60 days prior written notice or immediately upon a material breach.
Upfront Fee Payable Under Targeted Medical Education Agreement	99,600
Fee Payable Upon Supply Of First Specimen Under Targeted Medical Education Agreement	31,500
Fee Payable Upon Final Delivery Under Targeted Medical Education Agreement	31,500
Targeted Medical Education [Member] | Master Service Agreement [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Research and Development Expense, Total		131,000
A5 Genetics KFT [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Cost of Services, Licenses and Services			100,000
Additional License Fee Amount Paid				100,000
Additional License Fee Obligation Amount				1,200,000
Royalty Expense				50
Cost of Services				65
Affymetrix In [Member] | OwnerChip Program Agreement [Member] | Subsidiaries [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Payments for Software		21,590	94,723
Purchase Obligation	142,005	647,700
Contract Payable, Due in Rolling Year Two		51,600
NRLBH [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Minimum Purchase Under License Agreement to Acquire Right					$ 452,408